Nicola Biagio Mercuri, MD

1979- System Medicine Tor Vergata University, Roma, Italy- IRCCS Santa Lucia Foundation 
Dopamine and Basal Ganglia
"Nicola Biagio Mercuri"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tozzi A, Sciaccaluga M, Loffredo V, et al. (2021) Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Brain : a Journal of Neurology
Price R, Ferrari E, Gardoni F, et al. (2020) Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons. Pharmacological Research. 160: 105185
Sciamanna G, Ponterio G, Vanni V, et al. (2020) Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia. Cell Reports. 31: 107644
Imbriani P, D'Angelo V, Platania P, et al. (2020) Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data. Parkinsonism & Related Disorders. 74: 57-63
D'Angelo V, Paldino E, Cardarelli S, et al. (2020) Dystonia: Sparse Synapses for D2 Receptors in Striatum of a DYT1 Knock-out Mouse Model. International Journal of Molecular Sciences. 21
Ledonne A, Mercuri NB. (2019) On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity. International Journal of Molecular Sciences. 21
Napolitano F, De Rosa A, Russo R, et al. (2019) The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses. Scientific Reports. 9: 15294
Nicoletti CG, Landi D, Monteleone F, et al. (2019) Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis. Cns Drugs
Romoli M, Krashia P, Sen A, et al. (2019) Hippocampal epileptogenesis in autoimmune encephalitis. Annals of Clinical and Translational Neurology
Krashia P, Cordella A, Nobili A, et al. (2019) Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nature Communications. 10: 3945
See more...